Media Contact
Gail Fisher
Tuesday
Journal of the National Cancer Institute
Testing those diagnosed with a disease is the most efficient way to identify carriers of predisposing germline genetic variants, and is consistent with clinical practice guidelines. To achieve the goal of genetically targeted primary disease prevention, testing for an identified familial pathogenic variant must then extend to disease-free relatives in a process known as "cascade testing".
Monday
J Weekly
One in 40 Ashkenazi Jews has a gene mutation that drastically increases the chance of certain cancers — and Gail Fisher thinks people need to know about it.
Wednesday
Comprehensive Genomic Characterization of Breast Tumors with BRCA1 and BRCA2 Mutations
Germline mutations in the BRCA1 and BRCA2 genes predispose carriers to breast and ovarian cancer, and there remains a need to identify the specific genomic mechanisms by which cancer evolves in these patients. Here we present a systematic genomic analysis of breast tumors with BRCA1 and BRCA2 mutations, comparing these to common types of sporadic breast tumors.
Monday
Beyond The Headlines
This week's edition of "Beyond the Headlines" focuses on cancer. Do you know whether or not you are at greater risk of cancer due to a genetic mutation? It's not something we think about until we have a family member or a loved one who has been diagnosed with cancer. The BRCA genetic mutation could lead to breast or ovarian cancer, or perhaps other cancers. It is so dangerous that some people will take drastic surgical measures to prevent it.
Saturday
Belt It Out For BRCA!
The BRCA Foundation presents its inaugural San Francisco fundraiser, Belt It Out For BRCA! A Night at the Piano Bar. The evening will include an elegant dinner, dueling pianists, live auction items, mystery boxes and more! Guests are invited to sing along to classic songs. Dr. Pamela Munster, MD, and co-founder of the UCSF Center for BRCA Research will be honored. Laura Holmes-Haddad, notable cancer survivor due to personalized medicine, and author of the popular book, This is Cancer: Everything You Need to Know, will speak.
Wednesday
BRCA Foundation
The BRCA Foundation is thrilled to announce a new Podcast called "Positive Perspectives," an empowering and informative series of weekly conversations about hereditary cancer. We speak with survivors, "previvors," doctors, scientists, genetic counselors, and advocates, and we explore topics ranging from genetic testing and recovery after mastectomy, to cutting-edge therapies and prevention strategies.
Wednesday
San Francisco Business Times
BRCA Foundation Co-Founder Evan Goldberg Talks with BioFlash podcaster and SF Business Times Biotech Reporter Ron Leuty on why he is compelled to support cancer research, and what is on the horizon in the effort to prevent, treat and cure genetic cancers
Wednesday
Commonwealth Club
Cancer might be in your DNA. How does a BRCA mutation affect the risk of cancer for both men and women? How are genetic cancers different than other cancers, and who should be tested? Click below for our April 12 panel discussion at the Commonwealth Club of San Francisco, where leaders from the BRCA Foundation, Stanford University Medical Center, UCSF Helen Diller Comprehensive Cancer Center and Color Genomics joined a late stage ovarian cancer survivor to discuss genetic cancer, it's treatment, and prevention.
Wednesday
Gentry Magazine
Our founder, Evan Goldberg was featured in the GENTRY MAGAZINE's series "Secrets to Their Success" as one of 'ten fascinating Bay Area men who discuss life, love, career, and the pursuit of happiness.' Evan talks about his decision to fund research to "help create a world free from the threat of BRCA cancers."
Thursday
Healthcare Innovation
The V Foundation for Cancer Research, one of the leading funders of cancer research in the United States, is partnering with the San Francisco-based BRCA Foundation and the Gray Foundation to fund research of cancers that derive from BRCA or BRCA-like mutations.
Wednesday
Diginomica
NetSuite founder Evan Goldberg speaks to Diginomica about the motivations behind his cancer charity and his experience of running a non-profit organization – on NetSuite, naturally.
Wednesday
Fred Hutch News
A Fred Hutch researcher and breast cancer survivor talks about her inherited mutation and how it helped guide her decisions.
Wednesday
San Francisco Business Times
The (Color) test typically costs $249, but the BRCA Foundation partnership lowers that price to $50. The test, available in more than 150 countries, can spot risks of several other cancers, including colorectal, pancreatic, prostate, stomach and uterine cancers and melanoma.
Wednesday
San Francisco Chronicle
This lets them (patients) take charge of health and lets researcher have greater access to patients for these studies,” said Evan Goldberg, co-founder of the BRCA Foundation, a collaboration among UCSF, Stanford and Harvard, including the latter’s affiliated Dana-Farber Cancer Institute.
Wednesday
GenomeWeb
Color Genomics announced the Color Family Testing Program to offer genetic testing to parents, siblings, and adult children of patients with hereditary cancer mutations for $50 instead of $249. The program is supported by donations from the BRCA Foundation and private donors.
Wednesday
Buzzfeed
Parents, siblings, and adult children are eligible to take a Color test. A relative of someone with a BRCA mutation, for example, has a 50% chance of having the mutation, too, which can lead to breast or ovarian cancer. Color has partnered with private donors and the BRCA Foundation to subsidize the screening program.
Wednesday
Business Insider
Color Genomics is teaming up with the BRCA Foundation to launch a BRCA gene registry, so that people who have the BRCA mutations can opt in and be contacted for future research or clinical trials.
Monday
The Inquirer
He is not the first Silicon Valley entrepreneur to get involved in cancer research, but to Evan M. Goldberg, founder, chair and chief technology officer of integrated cloud-based business solutions provider Netsuite, the battle against this menace is a very personal matter.
Thursday
Upgrade Magazine
Among the illnesses all of us fear of having is cancer. And if you have the money, the passion, and the technology know-how to advance research about the Big C, you’ll definitely take an active role in fighting this disease, especially if you’re genetically-predisposed to it, like technopreneur Evan Goldberg.
Thursday
Malaya Business Insight
NetSuite’s founder and CTO Evan Goldberg and wife Cindy takes command of the BRCA Foundation, a philanthropic effort of the couple aimed at studying and finding cures to cancer.
Thursday
San Francisco Business Times
Evan Goldberg’s life changed six years ago — and with the help of two young Bay Area life sciences companies and a national network of cancer researchers, the founder of business software company NetSuite Inc. hopes to change the lives of thousands more people as well.
Saturday
Interaksyon
A Silicon Valley entrepreneur is giving a big boost to cancer research by making it his personal advocacy to support studies on gene mutations and BRCA cancers. NetSuite founder and chief technology officer Evan Goldberg announced recently that he is making a $10-million personal donation to the research fund.
Saturday
PaulWallbank.com
Netsuite founder Evan Goldberg hopes the lessons he’s learned from building a software company can help researchers find new ways to treat cancers.
Friday
The Jewish News Weekly of Northern California
Evan Goldberg, founder and chief technology officer of San Mateo-based NetSuite, began doing philanthropic work after his company went public in 2008. Some of his efforts went toward cancer research — and that was before he discovered he was a carrier of the BRCA1 gene mutation…
Friday
San Francisco Chronicle
"For me, the BRCA Foundation was a combination of an intellectual interest and a philanthropic interest in catalyzing new ways of looking at cancer ... and, of course, the personal interest in one day helping to treat and cure BRCA cancers for individuals and families such as my own,” said Goldberg…